Home›People›Stephen Van Deventer
Stephen Van Deventer

Stephen Van Deventer

Chief Executive Officer & President, director at BioGene Therapeutics.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Aug 7, 2026·Suggest an edit

About Stephen Van Deventer

Stephen Van Deventer is a chief executive officer & president, director at BioGene Therapeutics.

Experience

This experience comes from Stephen Van Deventer's profile and from SEC filings. For roles taken from filings, the years are when the filings name Stephen Van Deventer in the role, so the role may have started earlier or lasted longer.

BioGene Therapeutics Inc. Current
Chief Executive Officer & President, director
Chairman & CEO (2024 – Present)
2024 – Present · Austin, TX
Develops gene therapies for people with diabetes and obesity.
Asterion Cannabis Inc. Current
Chairman & CEO
2018 – Present
PreveCeutical Medical Inc. Current
Chairman & CEO
2015 – Present

Key Colleagues at Startups

The people Stephen Van Deventer works with at each company, as listed on that company's latest Form D.

BioGene Therapeutics Inc. · Form D, Aug 7, 2026
Steve Glover
Steve Glover
Board Member
DH
David Howton
Director
Raj Pruthi
Raj Pruthi
Independent Director
Patroski Lawson
Patroski Lawson
Independent Director
Deepak Sampath
Deepak Sampath
Independent Director

Sources

  1. SECBioGene Therapeutics Inc. Form D, filed Aug 7, 2026